New weekly pack could cut costs and fight child malnutrition
NCT ID NCT07540793
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in Ethiopia tests whether a new 7-day package of a nutritional supplement (SQ-LNS) works as well as the usual daily packets for preventing malnutrition in children aged 6-24 months. Researchers will compare how well families stick to using each package type over 8 weeks. The goal is to see if the new design is acceptable, safe, and leads to similar or better use, potentially lowering costs and improving distribution.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Small Quantity Lipid-based Nutrient Supplements (SQ-LNS)
What this could lead to
If successful, this could lead to cheaper, easier distribution of a supplement that helps prevent malnutrition in young children.
What could go wrong
This is a small, early-stage study focused on packaging and adherence, not on health outcomes. The new packaging may not be used as intended or could have safety issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALNUTRITION, CHILD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Debre Berhan University
Debre Berhan, Ethiopia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Heidelberg University
Heidelberg, Germany
-
Research Institute of Tropical Medicine
Manila, Philippines